UNSPSC 51262911: Bopindolol malonate

This classification denotes an adrenergic beta-antagonist C23H28N2O3.C3H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S3UWR70991, chemically known as propanedioic acid, compd. with (+/-)-2-((1,1-dimethylethyl)amino)-1-(((2-methyl-1h-indol-4-yl)oxy)methyl)ethyl benzoate (1:1), but more generally known as bopindolol malonate, which bears US NIH Compound Identifier 636368. European Medicines Agency schedules Bopindolol malonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00852MIG.

Most nations, for tariff and trade purposes, schedule bopindolol malonate under HS 29339990 and SITC 51577. As of Q4 2014, BOPINDOLOL MALONATE remains US FDA's Preferred Term for this commodity. SMILES: CC1CC2C([NH]1)CCCC2OCC(CNC(C)(C)C)OC(=O)C3CCCCC3.C(C(=O)O)C(=O)O.

UNSPSC 51262911 Bopindolol malonate is a Commodity code nominally identifying a specific beta-blocker pharmaceutical ingredient, but the recent state and local opportunities posted under this code show no purchasing activity for bopindolol malonate itself. Instead, the tagged solicitations address naloxone (an opioid antagonist) and pharmacy benefit program administration — products and services unrelated to the code's stated scope. State and local governments do not appear to be soliciting bopindolol malonate through this taxonomy entry at present.

The mismatch between the code's pharmaceutical designation and the actual work being tagged under it — naloxone procurement and direct-to-manufacturer prescription program planning — suggests either a cataloging error in the source data or that the code is being misapplied to broader pharmacy and health services activity. No relevant recent opportunities support active pursuit under this code's nominal scope.